Evidence map›Paper›PMID 31342112›Full record

ArticlePediatric cardiology2019

Impact of Characteristics at Stage-2-Palliation on Outcome Following Fontan Completion.

Keti Vitanova, Shuichi Shiraishi, Benedikt Mayr, Elisabeth Beran, Julie Cleuziou, Martina Strbad, Christoph Röhlig, Alfred Hager, Jürgen Hörer, Rüdiger Lange and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Keti VitanovaDepartment of Cardiovascular Surgery, German Heart Center Munich, Technische Universität München, Munich, Germany.
Shuichi ShiraishiDepartment of Cardiovascular Surgery, German Heart Center Munich, Technische Universität München, Munich, Germany.
Benedikt MayrDepartment of Cardiovascular Surgery, German Heart Center Munich, Technische Universität München, Munich, Germany.
Elisabeth BeranDepartment of Pediatric and Congenital Heart Surgery, German Heart Center Munich, Technische Universität München, Lazarettstraße 36, 80636, Munich, Germany.
Julie CleuziouDepartment of Pediatric and Congenital Heart Surgery, German Heart Center Munich, Technische Universität München, Lazarettstraße 36, 80636, Munich, Germany.
Martina StrbadDepartment of Pediatric and Congenital Heart Surgery, German Heart Center Munich, Technische Universität München, Lazarettstraße 36, 80636, Munich, Germany.
Christoph RöhligDepartment of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technische Universität München, Munich, Germany.
Alfred HagerDepartment of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technische Universität München, Munich, Germany.
Jürgen HörerDepartment of Pediatric and Congenital Heart Surgery, German Heart Center Munich, Technische Universität München, Lazarettstraße 36, 80636, Munich, Germany.
Rüdiger LangeDepartment of Cardiovascular Surgery, German Heart Center Munich, Technische Universität München, Munich, Germany.
Masamichi OnoDepartment of Pediatric and Congenital Heart Surgery, German Heart Center Munich, Technische Universität München, Lazarettstraße 36, 80636, Munich, Germany. ono@dhm.mhn.de.ORCID http://orcid.org/0000-0001-5699-6394

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The optimal timing of stage-2-palliation (S2P) in single left ventricle is not clear. The aim of this study was to identify S2P related factors associated with outcomes after total cavopulmonary connection (TCPC), particularly relative to the dominant systemic ventricle. A total of 405 patients who underwent both S2P and TCPC at our institute between 1997 and 2017 was included. Patients were divided into two groups, dominant right ventricle (RV type, n = 235) and dominant left ventricle (LV type, n = 170). S2P related factors associated with mortality, postoperative ventricular function, and late exercise capacity following TCPC, were analyzed. The median age at S2P was 4 [3-7] and 6 [3-11] months in RV and LV type patients, respectively (p = 0.092). Survival after TCPC was similar in RV and LV type patients (p = 0.280). In those with RV type, risk factors for mortality following TCPC were older age (p < 0.001), heavier weight (p = 0.001), higher PAP (p < 0.001), higher TPG (p = 0.010), and lower SO2 (p = 0.008) at S2P. In those with LV type, no risk factor was identified. Risk factors for postoperative impaired ventricular function were older age and higher weight at S2P in both RV and LV type patients. Older age at S2P was also identified as a risk for inferior peak oxygen uptake (VO2) years after TCPC both in RV and LV type patients. Older age at S2P was associated with higher mortality after Fontan completion only in RV type patients. However, it was associated with postoperative ventricular dysfunction and lower exercise capacity after TCPC in both RV and LV type patients.

Indexed as

Age FactorsChild, PreschoolFemaleFontan ProcedureHeart Defects, CongenitalHeart VentriclesHumansInfantMalePalliative CareRisk FactorsTreatment OutcomeVentricular DysfunctionDominant ventricleFontan completionStage-2-palliationTotal cavopulmonary connection

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.